How much longer for PAH sales teams?

Quote

anonymous

Guest
I've been on enough sales teams in my life that I can see there are some massive challenges coming up for PAH. Occasionally people actually give some useful/insightful info on here. It seems like unless the company acquires another drug, or gets another indication, they are done when UPV goes off patent in mid 26'. Wonder if anyone has any behind the scenes info. I know CP can be a dumpster fire, but someone seemed to have info about the CV layoff. Many thanks if you have any info.
 






I order the cars for the reps.

I just checked the company affiliate “no order list“ which means I can only replace if that’s necessary with one of our old Nissan vehicles I your groups case. The replacement fleet are parked outside in an out door lot near Newark airport sometimes for years.

In other words, we will not be ordering any new vehicles for your team.

In my 20 years here that indicates the end is upon the horizon And you will be unburden from what was shortly.

Enjoy the time you have left.
 






Not OP, nor 2nd idiot. I work in this division and several of us just ordered new cars. So that's clearly BS. Not sure on timelines either. My best guess is , this time next year if we haven't heard anything new, I'd start getting concerned. I think (?) everyone is in agreement no one is going anywhere until Uptravi goes off patent. That will be sometime around mid 26'. So you've got a full year - to a year and a half. After that, definite concerns exist. Just my thoughts, I guess we will see.
 






There were people in CVM who just ordered a new car and paid up on options just to be let go a few weeks later. Cars mean nothing... when they shut it down, it's shut down! Don't try to read the tea leaves, it only creates needless worry. When it hits you, consider it a blessing and move on.
 






car ordering is certainly a pointless measure for layoffs. However, someone seemed to be in the know for the CV division and was kind enough to give people a bit of a heads up. Maybe someone can shed some light here.
 


















anonymous said:
Plz stop spreading false info. There is literally zero chance of that. You’re clearly not in the disease state. Plz don’t troll on here. Peoples jobs and family are at stake. Have some basic dignity.
Click to expand...
Ex-CVM Rep here. I knew there was zero chance of the whole sales force getting let go. Er,………never mind…
 












anonymous said:
I've been on enough sales teams in my life that I can see there are some massive challenges coming up for PAH. Occasionally people actually give some useful/insightful info on here. It seems like unless the company acquires another drug, or gets another indication, they are done when UPV goes off patent in mid 26'. Wonder if anyone has any behind the scenes info. I know CP can be a dumpster fire, but someone seemed to have info about the CV layoff. Many thanks if you have any info.
Click to expand...
I'm in PAH also, mid 26' is what it sounds like to me too. Unless something changes with getting a new product. Hoping we can stick around,because I love this disease state and my current team.
 




































Surprised to see PAH on here, I've been here for years and I'm not sure I've ever seen a PAH post on C.P. Kinda glad to see some discussion about it though, because everyone is thinking about it. I guess I'll agree with the others. Start - Mid 2026 seems the current best guess. It seems like we are all hoping for Opsynvi to take off, but it will all come down to what insurances say. If there's a generic PDE5 and generic Opsumit, I don't see how Opsynvi will put through 1st line. Patients will have to show documented failure to the components first. The moment that happens, Mace portfolio is probably done. Uptravi will keep us around for a tiny bit longer, but not much. So pick any month between Jan - June of 2026. Somewhere around there, the PAH sales teams are done. Unless of course we acquire another product or company, but let's be real, that's a very slim chance. Hail mary that Mace 75 helps somehow too, but I just don't see it happening. Silly that we keep hearing about how good sales have been and how good our #s are and growth blah blah blah. None of that matters even 1% with regard to the future. Glad to see the topic at least on C.P., maybe someone has other insights.
 






anonymous said:
Surprised to see PAH on here, I've been here for years and I'm not sure I've ever seen a PAH post on C.P. Kinda glad to see some discussion about it though, because everyone is thinking about it. I guess I'll agree with the others. Start - Mid 2026 seems the current best guess. It seems like we are all hoping for Opsynvi to take off, but it will all come down to what insurances say. If there's a generic PDE5 and generic Opsumit, I don't see how Opsynvi will put through 1st line. Patients will have to show documented failure to the components first. The moment that happens, Mace portfolio is probably done. Uptravi will keep us around for a tiny bit longer, but not much. So pick any month between Jan - June of 2026. Somewhere around there, the PAH sales teams are done. Unless of course we acquire another product or company, but let's be real, that's a very slim chance. Hail mary that Mace 75 helps somehow too, but I just don't see it happening. Silly that we keep hearing about how good sales have been and how good our #s are and growth blah blah blah. None of that matters even 1% with regard to the future. Glad to see the topic at least on C.P., maybe someone has other insights.
Click to expand...
OP Loves using “seems” and “see” in sentences.

See it seems like he is a product of outcome based education.
 
























Top Bottom
Back
Quote